5-((3-(2,2,2-trifluoroethyl)guanidino)pyrazol-1-yl)valeramide,
ICI 162846,
ICI-162846,
ICI 162,846,
84545-30-2,
Ici 162846,
UNII-SJ96DC9C66,
SJ96DC9C66,
3-((Imino((2,2,2-trifluoroethyl)amino)methyl)amino)-1H-pyrazole-1-pentanamide,
ICI-162846,
3-((Imino((2,2,2-trifluoroethyl)amino)methyl)amino)1H-pyrazole-1-pentamide,
1H-Pyrazole-1-pentanamide, 3-((imino((2,2,2-trifluoroethyl)amino)methyl)amino)-,
5-[3-({imino[(2,2,2-trifluoroethyl)amino]methyl}amino)-1H-pyrazol-1-yl]pentanamide,
ALCSGJCIESECFD-UHFFFAOYSA-N,
Tocris-0833,
AC1Q4IIV,
SCHEMBL4099592,
SCHEMBL9366418,
CHEMBL1593717,
DTXSID5020734,
CHEBI:93167,
HMS3266J04,
HMS3675N15,
AC1L3585,
ZINC3995724,
AKOS024458664,
1h-pyrazole-1-pentanamide, 3-[[(1e)-amino[(2,2,2-trifluoroethyl)amino]methylene]amino]-,
ICI-162,846,
NCGC00024812-01,
NCGC00024812-02,
LS-128550,
B6465,
SR-01000597451,
SR-01000597451-1,
BRD-K66782112-001-01-2,
5-[3-(2-[2,2,2-trifluoroethyl]guanidino)pyrazol-1-yl]valeramide,
5-[3-[[N'-(2,2,2-trifluoroethyl)carbamimidoyl]amino]pyrazol-1-yl]pentanamide,
N-[1-(4-Carboxamidobutyl)-1H-pyrazol-3-yl)]-N'-(2,2,2-trifluoroethyl)guanidine,
C11H17F3N6O,
AR-1C3839,
C11-H17-F3-N6-O,
CID134778,
90389-38-1,